23 Sep 2025 Biotech Stocks Healthcare Stocks Life Sciences Small Caps Stocks Amplia Therapeutics (ASX:ATX): Battling pancreatic cancer with an FAK inhibitor Amplia Therapeutics (ASX:ATX) is another ASX oncology biotech company, attempting to battle cancer. At first glance, it may not a unique company but when you dig deeper...it is. It is… ByNick Sundich